Nandakumar Ravichandran

Mr. Nandakumar Ravichandran

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2025 in Irish Journal of Psychological Medicine
Verified
Journal Article
Open access
PDF file
NRNandakumar Ravichandran
Nandakumar Ravichandran
EDEmily Dillon
Emily Dillon
GMGeoff McCombe
Geoff McCombe
ESEmils Sietins
Emils Sietins
JBJohn Broughan
John Broughan
WCWalter Cullen
Walter Cullen
Background: Many consultations in primary care involve patients with mental health problems, and primary care is typically the place where many such patients initially seek help. While considerable research has examined the prevalence of mental health disorders in primary care, relatively few papers have examined this issue in recent years. This study aims to address this gap by reviewing contemporary literature from 2014 to 2024 on the prevalence of mental health disorders among general practice patients. Methods: A comprehensive search across PubMed, PsycINFO, and Google Scholar was conducted, adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines for article selection and assessment, examining the prevalence of mental health disorders in general practice. Results: Studies varied in methodologies and healthcare settings, with reported prevalence rates of mental health disorders ranging from 2.4% to 56.3%. Demographic characteristics (female gender, older age) were associated with a higher prevalence of mental health disorders in the studies identified. Studies based on patient interviews reported broader prevalence (2.4–56.3%) compared to studies using electronic medical record reviews (12–38%). Prevalence also varied between countries. Notably, there has been a lack of post-COVID-19 studies, especially within Europe, examining the prevalence of mental health prevalence in primary care. Conclusions: Mental health problems are still common among patients attending general practice; the approach to data collection (i.e., prospective interviews with patients), female gender and older age appear to be correlates of higher estimates. Further research involving a large-scale study with multiple sites is a priority.

9 May 2025 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
TSTheresa Sunny
Theresa Sunny
NRNandakumar Ravichandran
Nandakumar Ravichandran
JBJohn Broughan
John Broughan
GMGeoff McCombe
Geoff McCombe
SLSheila Loughman
Sheila Loughman
WCWalter Cullen
Walter Cullen
Virtual wards provide a promising alternative to traditional ‘bedded care’ by facilitating early discharges and delivering acute care at home. They focus specifically on patients needing acute care, which would traditionally necessitate an in-hospital stay. Understanding practitioners’ beliefs and attitudes is crucial for successful implementation and operation of Virtual wards. This scoping review explores practitioners’ perspectives on the implementation of virtual wards. A total of 18 studies were included in the final analysis from the 201 studies identified initially through searches in PubMed, Cochrane, CINAHL, and Embase databases (2015–2024) following PRISMA Extension for Scoping Reviews (PRISMA-ScR) guidelines. Thematic analysis was conducted using Braun and Clarke’s framework to identify key insights. Thematic analysis revealed key themes related to implementation, quality of care, technology, training, and awareness. These themes highlight the challenges influencing the adoption and considerations for the operational success of virtual wards. Virtual wards demonstrate significant potential for delivering acute care efficiently and sustainably. However, challenges related to service design, patient safety, technology integration, and workforce training must be addressed to ensure their successful implementation and long-term efficacy.

20 June 2026 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Open access
NRNandakumar Ravichandran
Nandakumar Ravichandran
DQDiarmuid Quinlan
Diarmuid Quinlan
PFPatricia Fitzpatrick
Patricia Fitzpatrick
EHEllen Hayes
Ellen Hayes
MMMick Molloy
Mick Molloy
WCWalter Cullen
Walter Cullen
Background: Community-onset sepsis accounts for most sepsis episodes, yet national-level data describing its epidemiology and outcomes remain limited in Ireland. Improved characterisation is needed to support prevention, early recognition, and service planning. Objectives: To examine the epidemiology, infection sources, comorbidity burden, and outcomes of adult (non-maternity) community-onset sepsis in Irish hospitals. Methods: We conducted a secondary analysis of Hospital In-Patient Enquiry data from all acute public hospitals in Ireland from January 2020 to December 2024. Sepsis admissions were identified using ICD-10-AM diagnostic codes. Demographic characteristics, comorbidity burden, infection source, critical care utilisation, and in-hospital mortality were analysed. Multivariable logistic regression was used to identify independent predictors of critical care admission and mortality. Results: Among 68,644 sepsis episodes, 49,268 (71.7%) were community-onset. Of these, 92.6% ( n = 45,641) were adult (non-maternity). In-hospital mortality among community-onset was 19.2%. Mortality increased significantly with age, with episodes of individuals aged ≥ 95 years having the highest odds of death (adjOR 9.17, 95% CI 7.31–11.52) compared to those aged 25–44 years. Increasing multimorbidity was independently associated with mortality; three or more comorbidities were associated with over threefold higher odds of death (adjOR 3.24, 95% CI 2.98–3.52). Respiratory infections (adjOR 2.05) were associated with increased mortality, while urinary sources were associated with lower mortality (adjOR 0.50). Conclusions: Community-acquired sepsis represents 72% of sepsis episodes in Ireland, predominantly affects older adults with multimorbidity. Prioritising prevention, early recognition, and timely management in the community including vaccination and prompt antibiotic treatment is essential to lowering morbidity and mortality.

13 June 2026 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Open access
JBJohn Broughan
John Broughan
YXYao Xie
Yao Xie
CCCrea Carberry
Crea Carberry
SOSarah O’COnnell
Sarah O’COnnell
JFJacinta Fay
Jacinta Fay
WCWalter Cullen
Walter Cullen
Background: Long Covid is a multi-factorial condition impacting millions globally. Aims: (1) To describe the demographic and health profiles of adults who have or have had Long Covid, and (2) examine their experiences of Long Covid healthcare, particularly in general practice. A cross-sectional online survey was conducted in the Republic of Ireland in April 2025. Methods: Survey items investigated demographics, medical history, and experiences of Long Covid care. Data was analysed using descriptive statistics and qualitative analysis of open responses. Results: Of 222 (87.05%) eligible respondents, most were 35–64 years (n = 184, 82.14%), female (n = 177, 79.7%), and born in the Republic of Ireland (n = 193, 86.9%). Respondents reported wide-ranging multimorbidity and Long Covid symptoms. Many strongly agreed that their symptoms were severe (n = 196, 88.7%) and detrimental to quality of life (n = 200, 90.1%), physical (n = 202, 91%) and mental (n = 98, 45%) health. Long Covid commonly lasted more than three years (n = 169, 76.1%), indicating substantial long-term impact on daily functioning. Almost all consulted general practitioners for Long Covid care (n = 213, 95.9%). Nearly half (n = 95, 44.6%) were dissatisfied with current GP care, and many felt GPs lacked adequate knowledge of Long Covid (n = 127. 59.6%). Respondents supported proposed GP-based investigative and referral interventions, as well as affirming and advocacy-focused doctor–patient relationships. Conclusions: Continued clinical and research efforts are needed to address future Long Covid care needs. With structured, informed, holistic, and multidisciplinary care, general practice can make a positive contribution to the lives of those affected.

2 October 2025 in HRB Open Research
Verified
Journal Article
Open access
PDF file
NRNandakumar Ravichandran
Nandakumar Ravichandran
JBJohn Broughan
John Broughan
GMGeoff McCombe
Geoff McCombe
SLSheila Loughman
Sheila Loughman
SKSokoine Kivuyo
Sokoine Kivuyo
WCWalter Cullen
Walter Cullen
Background Diabetes is a common comorbidity among people living with HIV. As the prevalence of diabetes rises across sub-Saharan Africa (SSA), there is an urgent need for effective interventions to address diabetes and pre-diabetic conditions in HIV patients. The META (Metformin Treatment in Africa) trial aims to assess the effectiveness of metformin in preventing diabetes among people living with HIV (PLHIV) on antiretroviral therapy (ART) who have pre-diabetes. This paper presents the process evaluation, which explores the feasibility, acceptability, and perceived effectiveness of the META trial and its intervention in real-world clinical settings in Dar es Salaam, Tanzania. Methods A mixed methods approach will be employed using a pragmatic realist theoretical framework. Qualitative data will be gathered through in-depth semi-structured interviews using stratified purposive sampling of trial participants (n=20), policymakers (n=10) and focus group discussions with associated health care providers and clinicians working in HIV and non-communicable disease care (n=20). Short cross-sectional surveys will be administered prior to interviews. Data collection will take place across five health facilities in Dar es Salaam, Tanzania. Qualitative data analysis will be complemented by Braun and Clarke’s ‘Reflexive Thematic Analysis’ technique, and survey data will be analysed using SPSS. Discussion The study’s pragmatic realist framework is expected to produce findings with greater depth, scope, and practical relevance. The study findings will contribute to existing knowledge regarding the experiential components of trials involving persons on ART and/or with pre-diabetes, as well as metformin-based interventions. Findings will support interpretation of trial outcomes, highlight facilitators and barriers to implementation, and provide evidence to guide future policy, scale-up, and integration of diabetes prevention strategies into HIV care in SSA. Process evaluation registration: Clinicaltrials.gov, NCT06743698 Trial registration: ISRCTN77382043

28 August 2024 in medRxiv
Verified
Preprint
Open access
PDF file
NRNandakumar Ravichandran
Nandakumar Ravichandran
PJParnian Jalili
Parnian Jalili
Background Monkeypox (mpox) is a zoonotic disease originating from the Congo Basin (Clade I) and West Africa (Clade II). In 2022, mpox spread to non-endemic European countries, predominantly through human transmission associated with sexual contact. The outbreak in Europe was primarily with the Clade IIb lineage, which is less virulent. The World Health Organization (WHO) declared this outbreak a Public Health Emergency of International Concern (PHEIC) in 2022, which ended in May 2023 after a decline in cases. However, in July 2024, a resurgence of the more virulent Clade I occurred in the Democratic Republic of Congo (DRC), leading WHO to declare mpox a PHEIC again, due to the risk of global spread. Understanding epidemiology and risk factors of mpox is vital for effective public health measures. Methodology and principal findings A PubMed search (2014-2024) identified 29 studies on mpox in Europe, which were included for qualitative analysis. The key themes identified were epidemiology, risk factors, and implications for public health actions. High-risk behaviors include sexual contact among men who have sex with men (MSM) with multiple partners, living with HIV, and frequent travel to endemic regions. Conclusions and significance With no definitive cure for mpox, public health measures such as surveillance, monitoring, and contact tracing are essential. Additionally, encouraging case-control studies is crucial for exploring other potential risk behaviors and design behavioral interventions, vaccination campaigns and awareness programs aimed at reducing high-risk behaviors among these populations. Although the number of cases in Europe did not surge in August 2024, proactive measures are necessary to prevent further spread. Author Summary In my study, I investigated the epidemiology and risk factors of Monkeypox in Europe and their implications for public health. The spread of Monkeypox in Europe is influenced by factors such as established transport networks, challenging living conditions, recreational drug use, and connections within LGBTQ+ communities. Understanding these risk factors is essential for developing effective public health strategies to prevent further outbreaks and future pandemics. These findings highlight the importance of these risk factors in shaping public health responses across Europe. By identifying these risks, this research aims to guide public health systems in implementing targeted measures. Additionally, the study advocates for exploring other potential risk behaviors, including practices among heterosexual individuals and those involving blood or intravenous drug use, areas that current research often overlooks. Overall, this work enhances our understanding of Monkeypox in Europe and identifies new areas for further investigation. By sharing these insights, I hope to contribute to ongoing efforts to address and manage tropical neglected diseases like Monkeypox.